Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses

BACKGROUND: Oncolytic viruses represent a novel form of cancer immunotherapy. Vaccinia viruses encoding human T cell co-stimulatory molecules have demonstrated clinical activity in phase I clinical trials in patients with advanced melanoma. However, predictive biomarkers of therapeutic response have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zloza, Andrew, Kim, Dae Won, Kim-Schulze, Seunghee, Jagoda, Michael C, Monsurro, Vladia, Marincola, Francesco M, Kaufman, Howard L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019911/
https://www.ncbi.nlm.nih.gov/pubmed/24829758
http://dx.doi.org/10.1186/2051-1426-2-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019911/
https://www.ncbi.nlm.nih.gov/pubmed/24829758
http://dx.doi.org/10.1186/2051-1426-2-1

Ejemplares similares